Matthew Budoff, MD: The Clinical Utility of Coronary Calcium Scoring
At HiD 2022, Dr. Budoff discusses the use and utility of coronary calcium scoring for risk stratification
The Pitfalls, Benefits of Influencing Dermatology Social Media
Savanna Perry, PA-C, discussed the challenge of standing out over influencers and estheticians regarding clinical dermatology insight, and the unique offerings of different platforms.
The Benefits & Challenges of Social Media Healthcare
Savanna Perry, PA-C, founder of The PA Platform, discusses the strategies and goals that go into building an online audience as a healthcare professional.
Jeffrey Cohen, MD: Addressing Depression and Anxiety in Women with Lichen Sclerosis
Dr. Cohen details the latest study from Yale, which indicated that women from lichen sclerosus had increased risk of developing depression and anxiety.
Akash B. Gadani, MD: The Importance of Diet for GERD
Dr. Gadani often suggests patients eat smaller meals and do not eat too close to bedtime.
Lisa Arkin, MD: Advancements in Scleroderma Treatment Strategies
Dr. Lisa Arkin speaks to how evidence-based, expert opinion-led consensus treatment plans for scleroderma can help change the way patients and providers approach the disease.
Kelly Cordoro, MD: Diagnosing and Treating Pediatric Scleroderma
Dr. Cordoro speaks on the prevalence of variants of scleroderma in children, and how provides can better recognize and treat the disease in pediatric populations.
Uncovering Clinical Meaning of Sleep in Early Cognitive Development
Mark Blumberg, MD, discusses his laboratory's particular interest in early REM sleep movement, and its potential impact on neurological disorders.
Sarah Bermudez, PharmD: SGLT2 Inhibitors Underutilized in Heart Failure Care
The late-breaking data show SGLT2is are underutilized in patients with heart failure with or without type 2 diabetes despite guideline recommendations.
Roy Taylor, MD: Using Personal Fat Thresholds to Reach Type 2 Diabetes Remission
The diabetologist and professor discusses new findings from the ReTUNE trial, which disparage the utility of BMI in defining diabetes risk and remission opportunity.
Adalberto Gonzalez, MD: Furthering the Safety of IBD Treatments
In recent years more and more biologics have come on the market for the treatment of IBD.
Educating Psychiatry Trainees on Social Determinants of Health
A Montefiore residency director explains the impact of engaging with communities to improve mental health care capability.
Adalberto Gonzalez, MD: The Safety of Biologics for IBD
In data presented at DDW, there was no evidence found showing biologics result in an increased risk of developing malignancies for patients with IBD and PSC.
Yoga vs Antidepressants: Defining Workplace Burnout Over Mental Health Issues
Montefiore's Carol A. Bernstein, MD, discusses the role of psychiatry specialists in discerning their colleagues' need for mental health care or resolutions to burnout.
Millie D. Long, MD: Expanding the Safety Data on Ustekinumab
New data suggests there is no connection between ustekinumab and the risk of malignancies.
Paul Feuerstadt, MD: The Future of C Difficile Treatment
There are several companies preparing new treatments for recurrent C difficile infections.
Kanika Sehgal, MBBS: The State of C Difficile Care
There are several potential treatments on the horizon for C difficile infections.
Sleep Pharmacotherapy, Melatonin, and the Link to Substance Use Disorders
Gina Poe, PhD, discusses the potential role of beta blockers in treating psychiatric illness-related sleep, as well as the specific benefit of melatonin.
Mental Health Disparities Among the Hispanic Population
NIDA research director Carlos Blanco-Jerez, MD, PhD, reviews how stigma, language barriers and digital health create disparate outcomes in mentally-ill Hispanic patients.
The New Era of Borderline Personality Disorder Care
Lois Choi-Kain, MD, MEd, discusses her field's interest in improving the modern diagnosis and evidenced-based treatment of personality disorders.
Gina Poe, PhD: How Psychiatric Diseases Impact Sleep Health
The UCLA-based investigator discusses the unique impact of PTSD on patients' sleep stages, and how they can limit their insomnia.
Millie Long, MD: The Safety of Ustekinumab
Patients treated with ustekinumab are not at an increased risk of malignancies.
Nora D. Volkow, MD: The Pain Crisis, and Optimizing Addiction Care Delivery
The director of NIDA discusses the interplay of substance use disorder and pain in patients, as well as means to assure patients are receiving evidenced-based treatment.
Identifying and Treating Adolescent Borderline Personality Disorder
Lois Choi-Kain, MD, MEd, discusses the unique presentations of disease and burdens of care that impact younger patients with BPD.
The Psychiatry Blueprint to Retaining Diverse Trainees, Treating Disparity
The modern psychiatrist may play many roles, including as a mentor and a facilitator to social-based support.
Paul Feuerstadt, MD: New Data on RBX2660 at DDW 2022
There are several live microbiota therapeutics in development, including RBX2660.
Bruce Sands, MD: Safety of Ustekinumab Among Bionaive Patients with IBD
Data show the safety profile of Ustekinumab in long-term IBD pooled safety dataset was found favorable among bionaive patients.
Jean-Frederic Colombel, MD: Promising Data on Upadacitinib for Crohn's Disease
The treatment has previously been approved by the FDA for the treatment of ulcerative colitis.
Challenges in Psychiatry Patient Disparities and Caregiver Representation
Rachel Talley, MD, discusses the industry-level changes needed to trainee recruitment and retention to create a psychiatry field more representative of its patient population.
Aasma Shaukat, MD, MPH: Better Detection on Colonoscopies
The age of screening for colon cancer has decreased in recent years.